Clinical Trial Update: Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) Study [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describing a blood sample collection study for pharmacogenomic characterization in participants who previously received namiluma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Namilumab (namilumab)

Snippet

Sponsor: Takeda | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2018-01-02